Bioequivalence and adhesion evaluation of transdermal clonidine following a change in excipient supplier
{{output}}
Objective: To evaluate the bioequivalence (BE), safety, tolerability, and adhesion of Oppanol® polyisobutylene (PIB)-containing transdermal therapeutic system (TTS) formulation (test treatment, T) with VistanexTM PIB-containing ... ...
